This review article from Florence Bedos-Belval and co-workers at Université Paul Sabatier examines the possibility of diaryl ethers as a promising frame to design new anti-cancer agents.
- A look at encompassing synthesis,
- Structure–activity relationships (SARs),
- Studies on the biological action, namely in the context of anti-cancer activity.
Bedos-Belval et al. aim for this review is to show that the diaryl ether scaffold is an invaluable structure for the design of anticancer drugs.
Curious about diaryl ethers as anticancer agents? Read the full review today.
Diaryl ether derivatives as anticancer agents – a review
Florence Bedos-Belval, Anne Rouch, Corinne Vanucci-Bacqué and Michel Baltas